(Q34105478)

31 July 2017

1 reference

title

Recent advances in the use of vitamin A (retinoids) in the prevention and treatment of cancer (English)

1 reference

31 July 2017

0 references

1 reference

1 reference

Niles RM

1

1 reference

31 July 2017

language of work or name

1 reference

1 November 2000

1 reference

31 July 2017

1 reference

31 July 2017

volume

16

1 reference

31 July 2017

issue

11-12

1 reference

31 July 2017

page(s)

1084-1089

1 reference

Control of retinoid nuclear receptor function and expression

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

The Molecular Basis of Visual Excitation

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

VITAMIN A AND REPRODUCTION IN RATS

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

The retinoid signaling pathway: molecular and genetic analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Identification of a receptor for the morphogen retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

A human retinoic acid receptor which belongs to the family of nuclear receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Transfer of retinoic acid from its complex with cellular retinoic acid-binding protein to the nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Nuclear Detection of Cellular Retinoic Acid Binding Proteins I and II with New Antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Chromosomal assignment of retinoic acid receptor (RAR) genes in the human, mouse, and rat genomes

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

A functional retinoic acid receptor encoded by the gene on human chromosome 12

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Mapping of the mouse Rxr loci encoding nuclear retinoid X receptors RXR alpha, RXR beta, and RXR gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Limited specificity and large overlap of the functions of the mouse RAR gamma 1 and RAR gamma 2 isoforms

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

RXR gamma null mice are apparently normal and compound RXR alpha +/-/RXR beta -/-/RXR gamma -/- mutant mice are viable.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Cell-type and promoter-context dependent retinoic acid receptor (RAR) redundancies for RAR beta 2 and Hoxa-1 activation in F9 and P19 cells can be artefactually generated by gene knockouts

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Targeted disruption of retinoic acid receptor alpha (RAR alpha) and RAR gamma results in receptor-specific alterations in retinoic acid-mediated differentiation and retinoic acid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

The targeted disruption of both alleles of RARbeta(2) in F9 cells results in the loss of retinoic acid-associated growth arrest.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

RAR-beta 4, a retinoic acid receptor isoform is generated from RAR-beta 2 by alternative splicing and usage of a CUG initiator codon

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Murine isoforms of retinoic acid receptor gamma with specific patterns of expression

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Identification of a novel isoform of the retinoic acid receptor gamma expressed in the mouse embryo

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Ligand specificities of recombinant retinoic acid receptors RAR alpha and RAR beta

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

9-cis retinoic acid is a high affinity ligand for the retinoid X receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Sequence and characterization of a coactivator for the steroid hormone receptor superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Lineage-specific signaling in melanocytes. C-kit stimulation recruits p300/CBP to microphthalmia

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

p27Kip1: a key mediator of retinoic acid induced growth arrest in the SMS-KCNR human neuroblastoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Posttranslational regulation of cyclin D1 by retinoic acid: a chemoprevention mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Induction of p21(CIP1/Waf1) and activation of p34(cdc2) involved in retinoic acid-induced apoptosis in human hepatoma Hep3B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Retinoic acids induce growth inhibition and apoptosis in adult T-cell leukemia (ATL) cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Effect of retinoids on AOM-induced colon cancer in rats: modulation of cell proliferation, apoptosis and aberrant crypt foci.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Suppression of rat mammary cancer development by N-(4-hydroxyphenyl)retinamide (4-HPR) following surgical removal of first palpable tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Suppression of apoptosis by all-trans-retinoic acid. Dual intervention in the c-Jun n-terminal kinase-AP-1 pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

High dietary retinoic acid prevents malignant conversion of skin papillomas induced by a two-stage carcinogenesis protocol in female SENCAR mice

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Diversity in function and regulation of MAP kinase pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

13-cis-retinoic acid in the treatment of oral leukoplakia

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Clinical models of chemoprevention for the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Long-term therapy with low-dose isotretinoin for prevention of basal cell carcinoma: a multicenter clinical trial. Isotretinoin-Basal Cell Carcinoma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. The Skin Cancer Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Prevention of cervical intraepithelial neoplasia and cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Chemoprevention of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Cancer chemoprevention: progress and promise

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Evidence for a 15; 17 translocation in every patient with acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

The effects of 13-cis retinoic acid and interferon-alpha in chronic myelogenous leukemia cells in vivo in patients

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Treatment of patients with low-risk myelodysplastic syndromes using a combination of all- trans retinoic acid, interferon alpha, and granulocyte colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Enhanced potency of 9-cis versus all-trans-retinoic acid to induce the differentiation of human neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Retinoids in neuroblastoma therapy: distinct biological properties of 9-cis- and all-trans-retinoic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Interferon-gamma and retinoic acid down-regulate N-myc in neuroblastoma through complementary mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Retinoic acid stimulates IGF binding protein (IGFBP)-6 and depresses IGFBP-2 and IGFBP-4 in SK-N-SH human neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Retinoic acid receptor beta mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Clinical significance of erbB-2 (HER-2/neu) protein

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Expression of c-erbB-4/HER4 is regulated in T47D breast carcinoma cells by retinoids and vitamin D3

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Successful treatment of relapse of acute promyelocytic leukemia with a new synthetic retinoid, Am80

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Multiple members of the retinoic acid receptor family are capable of mediating the granulocytic differentiation of HL-60 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Use of retinoic acids in the treatment of peripheral T-cell lymphoma: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

A phase II trial of isotretinoin and alpha interferon in patients with recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

Oxygenation of cervical cancers during radiotherapy and radiotherapy + cis-retinoic acid/interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2800%2900436-6

7 January 2021

10.1016/S0899-9007(00)00436-6

Identifiers

DOI

1 reference

31 July 2017

1 reference